A multimedia link in The New York Times about cystic fibrosis details how the use of evidence-based  and peer-reviewed research and medicine evolves into a best practice and brighter futures for patients with cystic fibrosis.

Cystic fibrosis affects 70,000 children and adults worldwide, according to the article. Treatment for cystic fibrosis has evolved from its rudimentary dietary suggestions of the 1950s to adult-only medication in the 1980s to today's specialized care centers and treatment programs.

"Today, physicians say the most exciting avenue of research involves new drugs that could address the root of the problem," which is genetic, the article reported.

Its wonderful to be able to map out the revolutionary betterment of medicine, just as the multimedia piece has done. AllMed, an independent review organization, in essence, maps out each disease via treatment as its in-house and contracted doctors work to provide payers and hospitals with the most up-to-date treatment plans.

To read the full article, click here: http://health.nytimes.com/ref/health/healthguide/esn-cystic-fibrosis-ess.html?ref=health